Navigation Links
NeoClinical Launches Neo PayPerPatient Clinical Trial Recruitment
Date:2/20/2013

Palo Alto, CA/ Sydney, Australia (PRWEB) February 20, 2013

NeoClinical™, the leading digital clinical trial recruitment agency for Australia, New Zealand and Asian markets today officially launched its latest recruitment product, Neo PayPerPatient. Neo PayPerPatient has emerged from 6 months of beta testing, including regulatory compliance, and integration of some of the latest online consumer engagement software and tools.Neo PayPerPatient has already built powerful databases of people wanting more information about the latest clinical trials for conditions including gout, arthritis, Alzheimer’s, menopause, diabetes, prostate cancer and asthma.

Get the PayPerPatient Data Sheet here.

Neo PayPerPatient is a risk share pay-as-you-go solution for new studies or current studies that are under-performing and need a boost to recruitment.Sponsors only pay a nominal fee for partially screened patients then a moderate fee for those that proceed to full enrolment. NeoClinical™ manages all the rest.

NeoClinical™‘s advertising and PR expertise as well as the team’s considerable online and social media experience is already delivering results for clients – saving money and most importantly time. NeoClinical™ study recruitment campaigns feature innovative and EC compliant advertising, public relations and online content marketing campaigns. With more than 80% of internet users seeking health information online and a third of US adults online to look at health information, getting in front of people online is key.

“Dr. Google is where it is all happening, but you need to give people quality informative content that answers their online search,” said co-founder Susan Fitzpatrick-Napier. “NeoClinical™ is a trusted source for original and authentic health news that informs and updates our potential patients.”

NeoClinical™ typically achieves referral conversion rates of 40-60% and recently achieved a 63% conversion rate for a New Zealand Study.

“For too long companies have been spending valuable time and money searching for people. Don’t waste money finding people you don’t need. Just make it easy for people you need to find you,” said Fitzpatrick-Napier.

For more information about the latest research and new clinical trials please visit http://www.NeoClinical.com.

About NeoClinical™ http://www.neoclinical.com
NeoClinical™ is the region's foremost clinical trial marketing agency dedicated to sharing news on the latest clinical research in Australia, New Zealand, and Asia including Korea, Taiwan, Malaysia, India and China.
NeoClinical™ uses the latest population health data and media consumption data to communicate via a sophisticated mix of public relations, advertising and online content marketing. This is combined with the highest level of reporting, measurement and analytics.
NeoClinical™ is headed by award-winning communications executives who have managed global campaigns for some of the world’s leading consumer and healthcare companies.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10440216.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
4. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
5. Neogen Launches Fully Quantitative Lateral Flow Test for DON
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. iHealth Lab Launches Personalized Web Portal to Store Your Vitals
8. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
9. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
10. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
11. ERT Launches New Website to Support Significant Commercial Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... ... and manufacturing company, today announced several positive developments that position the Company for ... a result of the transaction, Craig F. Kinghorn has been appointed Chairman of ...
(Date:5/25/2016)... ... May 25, 2016 , ... Thailand’s Board of Investment’s New ... San Francisco. Located at booth number 7301, representatives from the Thai Government, research ... the Thai biotechnology and life sciences sector. , Deputy Secretary General of ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... for information (RFI) issued by the Office of the National Coordinator for Health ... experience, and determines if clinically relevant data were available when and where it ...
(Date:5/25/2016)... FL (PRWEB) , ... May 25, 2016 , ... Lady ... eight she tore her cruciate ligament in her left knee. Lady’s owner Hannah sought ... a central Florida board-certified veterinary surgeon, to repair her cruciate ligament and help with ...
Breaking Biology Technology:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
Breaking Biology News(10 mins):